Continuity Biosciences Acquires Focal Medical to Advance Targeted Drug Delivery for Pancreatic Cancer
BRADENTON, Fla., June 4, 2025 /CNW/ -- Continuity Biosciences, LLC, a developer of advanced drug delivery technologies, announced today the acquisition of Focal Medical, Inc., a North Carolina-based biopharmaceutical company pioneering site-specific chemotherapy using iontophoresis. The acquisition represents a key step in Continuity's strategy to become a leader in device targeted therapeutics for intractable solid tumors.
Founded by leading scientists and clinicians, Focal Medical has developed a proprietary platform that delivers chemotherapy directly to tumors using iontophoresis —this minimally-invasive technique utilizes a mild electrical current to drive therapeutic compounds into targeted tissues. This method enhances local drug concentration while minimizing systemic toxicity, a critical need in the treatment of pancreatic and other solid-tissue cancers.
Focal Medical's lead product candidate, an iontophoresis device directed gemcitabine therapy for pancreatic cancer, has been cleared by the U.S. Food and Drug Administration (FDA) through an Investigational New Drug (IND) application. Phase 1b clinical trials are expected to begin later this year.
"This is a transformative milestone for Continuity Biosciences," said Ramakrishna Venugopalan, PhD, MBA, Chief Executive Officer of Continuity Biosciences. "Focal Medical's approach to localized drug delivery aligns perfectly with our vision to improve bioavailability, reduce systemic exposure, and deliver better outcomes for patients. We are thrilled to bring this promising platform into our portfolio and into the clinic."
Through the acquisition, Continuity Biosciences obtains Focal Medical's entire patent estate, iontophoresis technology platform and specialized equipment, scientific know-how, and licensing agreements with the University of North Carolina at Chapel Hill. In addition, key scientific staff and leadership from Focal will join Continuity, further enhancing its internal capabilities. A dedicated research and development facility in Cary, NC that supports ongoing platform and pipeline advancement is also part of the acquisition and will be expanded to support other delivery platforms.
Visionary Founders Driving the Innovation
Focal Medical was co-founded by:
Jen Jen Yeh, MD, a surgical oncologist and professor at UNC-Chapel Hill with joint appointments in Surgery and Pharmacology. She serves as assistant dean of translational research in UNC School of Medicine and associate director of translational research in UNC Lineberger Comprehensive Cancer Center. Dr. Yeh is widely recognized for her expertise in pancreatic cancer and translational oncology.
Joseph DeSimone, PhD, an award-winning chemist, entrepreneur, and academic, currently serving as the Sanjiv Sam Gambhir Professor of Translational Medicine and Chemical Engineering at Stanford University. He is globally known for his breakthroughs in materials science, nanomedicine, and advanced manufacturing, including 3D printing.
Their iontophoresis system is designed to deliver gemcitabine, an FDA-approved chemotherapy agent, directly into pancreatic tumors. Traditional systemic administration of gemcitabine is often limited by poor tumor penetration and significant toxicity. Focal's approach bypasses those limitations by delivering the drug directly to the tumor site with high precision and minimal systemic toxicity.
"After nearly a decade of R&D, we are excited to join the Continuity Biosciences family," said Tony Voiers, Acting CEO of Focal Medical. "We are grateful to our founders, scientific collaborators, and investors who have helped us reach this pivotal point. Partnering with Continuity ensures that this novel therapy moves forward into the clinic where it has the potential to help patients facing one of the deadliest cancers."
This acquisition reinforces Continuity Biosciences' commitment to building a diverse portfolio of clinically meaningful drug delivery platforms and signals a decisive move toward becoming a clinical-stage leader in site-specific therapy.
About Continuity Biosciences
Continuity Biosciences, LLC is a biopharmaceutical company developing advanced drug delivery technologies that address the limitations of conventional therapeutic administration. With operations in Bradenton, FL; Houston, TX; Raleigh, NC; and Torino, Italy, the company focuses on combination drug-device platforms for chronic and complex conditions.
Visit:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Vancouver Sun
an hour ago
- Vancouver Sun
Anthony Gismondi: Canadian wine has never been better as national awards mark 25th year
As you read this, I will be embarking on my 25th year at the WineAlign National Wine Awards of Canada in Penticton. Toronto-based writer and critic David Lawrason and I established the original awards to reliably assess the quality of Canadian wines on an annual basis. Over the last quarter century, the awards have produced a moment-in-time snapshot of the state of Canadian wine. Most of the first two decades mirrored the growth of wine and wine quality across Canada, while the last five have been marked by the chaos of a global pandemic and a variety of climate events, ranging from wildfire smoke and deep freezes to heat domes and drought, interspersed with some exceptional vintages and vigneron resilience lit amid the chaos. Our vision for a national competition encompassed participation from across the country, both by wine producers and judges and aimed to provide consumers with valuable insights regardless of their location. As we celebrate our 25th anniversary, we are proud to have achieved widespread industry participation despite the provinces' continuing restrictions on the free movement of wine within Canada. Discover the best of B.C.'s recipes, restaurants and wine. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of West Coast Table will soon be in your inbox. Please try again Interested in more newsletters? Browse here. British Columbia and Ontario dominate the entries, supplemented by increasing contributions from Quebec, Nova Scotia and other regions, creating a comprehensive picture of Canadian wine. The credibility of the awards is bolstered by the participation of virtually all of the country's most significant wineries. That does not happen anywhere else. We should note that mead and cider producers have also joined the show, albeit in modest numbers. This year's judging panel consists of 25 experts, slightly more women than men, hailing from several cities across Canada, as well as from San Francisco and London, England. We have introduced a mentorship program for young professionals over the years, providing apprentice judges with valuable experience alongside the nation's top sommeliers, retailers, buyers and wine critics. So, what can we say about Canadian wine after two and a half decades? It has never been better. The most significant gains have occurred in the last five years, as significantly improved viticulture has finally provided us with the raw material that reflects our wealth of unique terroir and climate. When we began The Nationals, Icewine ruled the day. Like Sauternes, it is somewhat out of fashion today, as Syrah, Chardonnay, Cabernet Franc and Pinot Noir dominate the stage. Syrah has been a mainstay category for quality at The Nationals. Still, since 2023, the complex grape has suffered significant damage in B.C. from two major freeze events, and its future looks uncertain as owners assess the risks and rewards of growing it again in the future. In the same vein, there is an opportunity for Grüner Veltliner, Semillon, Chenin Blanc and, as we warm up, even Cabernet Sauvignon. Nothing stays the same. Our best wines are turning heads, but sadly, we have yet to find our feet in the export markets, mainly because we sell everything we make in Canada. There is plenty to celebrate, and we suggest you do so with Traditional Method sparkling wines made in Canada, now showing up at celebrations across the nation. They are the perfect example of a true cool-climate wine, offering the ideal balance of acidity while allowing for an appropriate level of ripeness to produce outstanding sparklers from Nova Scotia to British Columbia. It should be a great week. Look for our report when the results are out in mid-July. $16.99 | 89/100 UPC: 3760040420127 The Paul Mas Viognier originates in Languedoc, France, a region known for the concept of 'Luxe Rural,' or rural luxury. The wine style is influenced by the warmth of the south, offering aromas of ripe apricots and peaches with a hint of florals. On the palate, it presents rich stone fruits complemented by hints of honeysuckle and spice. It is a versatile table wine that pairs well with grilled shrimp, roast chicken, vegetarian stir-fries, mild curries or soft cheeses like Brie or Camembert. $31.39 I 91/100 UPC: 808755006236 Severe winter temperatures resulted in notably reduced Chardonnay yields in 2023. Despite the limited crop, the quality is exceptional, characterized by excellent flavours and acidity balance. The warmer-than-usual conditions have contributed to this Naramata Chardonnay displaying a slightly richer texture that matches its complexity. Orange, tangerine, peach and hazelnuts combine to complement the oak, resulting in a well-balanced, delicious Next World Chardonnay that is somewhat reminiscent of a Western Australian Leeuwin Estate. The price remains a rare Okanagan bargain — winery direct or private wine shops. Price: $32 | 90/100 UPC: 776545502315 The 2024 Red Barn pink is the first replacement wine released by winemaker Kaylee Barrs. Fittingly, to fill the 'gap' left by the damage wreaked at Jagged Rock Vineyard, which, by the way, is well on its way to recovery, is a Pinot Noir from the Petaluma Gap, a large 200,000-acre AVA that stretches from San Pablo Bay to Bodega Bay. The styling is Red Barn, from its barely there colour to its subtle mix of dry red fruits and acidity. Sleek and pure, it fits the gap to a T. Impressive. $29.99 I 90/100 UPC: 628055147107 Bartier's '22 Franc is a mix of fruit from Cerqueira Vinyard (Black Sage Bench) and Blind Creek Vineyard (Similkameen), with minor additions of Syrah and petit verdot. The colour, nose and palate are rich and deep, with scents of black fruits, baking spices and minerals. There is a modicum of light tannin that will dissipate over the next year, leaving a mostly warm, friendly, lush south Okanagan red you can confidently serve with grilled vegetables, pork or beef. $34.99 I Score 90/100 UPC: 818201022161 Le Volte dell'Ornellaia is designed for earlier consumption compared to the flagship Ornellaia due to its softer tannins and brighter fruit. The 2022 blend comprises 51 per cent Cabernet Sauvignon, 44 per cent Merlot, and 5 per cent Petit Verdot, with an alcohol content of 13 per cent. It has floral and light toast aromas and a palate that includes blackberries, red plums, dried herbs, and black olives. This wine can be consumed now or stored for future use. • If you are planning to visit Vancouver Island this summer and want to catch up on the wine scene, Blue Grouse Vineyards has a spectacular venue in the Cowichan Valley and a wide assortment of offerings for you, including a sit-down, in-depth guided tasting of five wines, pack a picnic or on-site food offerings when you book a table and buy a bottle of wine. Neapolitan Pizzas and a bottle make for a fun afternoon looking over the vineyards. All and more are available by reservation at Visit Blue Grouse . Experience prices vary, starting at $15.99 per person. • The Fairmont Waterfront Garden Dinner Series has upcoming evenings scheduled for July 24 and Aug. 21. Enjoy a multi-course menu by executive chef Harris Sakalis, paired with wines from Burrowing Owl Estate Winery (July 24) and Quails' Gate Estate Winery (Aug. 21). The event features vintage cellar selections, insights from collaborators such as Chief Beekeeper Julia Common and Dave Wayward of Wayward Distillery, and dishes with rooftop honey and signature gin-based cocktails. Book your seat at the Garden Dinner Series – Fairmont Waterfront . $24.99 I 90/100 UPC: 776545993069 What can I say? This wine is as good as it was when tasted last year, if not better. The MHFE Reserve Rosé originates from southern estate vineyards in Osoyoos and Oliver. In 2022, it has a clean, crisp, fresh and bright profile. It features a blend of red fruit, including watermelon, strawberry and rhubarb, with subtle sweetness and no detectable sugar. Suitable for pairing with prawns, crab cakes, olives, and more, this style of rosé is easily comparable to those produced in Provence. $20.99 I 88/100 UPC: 8011204007650 This 85 per cent Glera and 15 per cent Pinot Noir blend is grown in light, stony soils. The two varieties are fermented separately and left on their fine lees until the second fermentation, which ends just off-dry, with approximately 11 grams of sugar per litre. The mix spends 60 days in a pressurized tank at 12°C, producing a persistent and creamy foam. Orchard fruits with a hint of vegetal notes provide balance, making this Prosecco the perfect late-afternoon aperitif. Organically certified and suitable for vegan diets, this Prosecco hits all the right notes for its price and the packaging.
Cision Canada
17 hours ago
- Cision Canada
SILVER VIPER COMPLETES ACQUISITION OF CIMARRON GOLD-COPPER PROJECT
VANCOUVER, BC, June 20, 2025 /CNW/ - Silver Viper Minerals Corp. (" Silver Viper" or the " Company") (TSXV: VIPR) (OTC: VIPRF) is pleased to announce that, further to its news release dated May 8, 2025, the Company has acquired the Cimarron Project in Sinaloa, Mexico, a property hosting a porphyry gold-copper system (the " Transaction"), from CSAC Holdings Inc. (" CSAC"). Pursuant to the terms of a purchase agreement dated May 8, 2025, between the Company, CSAC and all of the shareholders of CSAC (the " Vendors"), Silver Viper acquired all of the outstanding common shares of CSAC from the Vendors in exchange for 9,000,000 common shares at a deemed price of $0.20 per share, of Silver Viper (the " Shares"). The Shares issued to the arm's length Vendors are not subject to a hold period under applicable Canadian securities laws and no finders' fees were paid in connection with the Transaction. Highlights of the Cimarron Project The Cimarron Project is located on the prolific porphyry belt from Arizona to Jalisco and is situated in the well-established mining jurisdiction of Mexico. The Cimarron Project lies between Mazatlán and Rosario in Sinaloa and is accessible via an 11-kilometre dirt road from a nearby paved road. The area is relatively flat, with low topographic contrast, supporting ease of access. An electrical line passes one kilometre south of the property. The nearby towns of Rosario—a historic mining community—and Mazatlán provide access to skilled local labour. Qualified Person The technical information in this news release has been prepared in accordance with Canadian regulatory requirements set out in NI 43-101 and reviewed and approved by Ben Whiting, a Qualified Person as defined in NI 43-101. About the Company Silver Viper Minerals Corp. is a Canadian-based junior mineral exploration company focused on precious metals exploration in Mexico. The Company is the operator and 100% owner of the La Virginia Gold-Silver Project in Sonora. The Company continues to evaluate and advance mineral exploration opportunities across key mining jurisdictions in Mexico and acquired the Cimarron Project in Sinaloa, Mexico in June 2025. ON BEHALF OF THE BOARD OF DIRECTORS, Steve Cope President and CEO Follow us on social media: X: @SilverViperCorp LinkedIn: Silver Viper Minerals Corp. Facebook: Silver Viper Minerals YouTube: @SilverViperMinerals Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward Looking Information This news release includes forward-looking statements that are subject to inherent risks and uncertainties. All statements within this news release, other than statements of historical fact, are to be considered forward looking and include, without limitation, any statements respecting future plans for the Cimarron Project. Although Silver Viper believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those described in forward-looking statements. Factors that could cause actual results to differ materially from those described in forward-looking statements include fluctuations in market prices, including metal prices, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. SOURCE Silver Viper Minerals Corp.
Calgary Herald
21 hours ago
- Calgary Herald
AIMCo seeks new CIO amid push to expand Calgary office
Article content Alberta Investment Management Corp. is hunting for a new chief investment officer as it carries out an overhaul that began last year when the provincial government fired the board and its top executive. Article content The new CIO would be based in Calgary, the largest city in Alberta and the home of Canada's major oil and gas companies. Edmonton-based Aimco is considering both internal and external candidates, according to people familiar with the matter, asking not to be identified because they weren't authorized to speak publicly. Article content Article content Article content Four people held the CIO title at Aimco in less than four years. The most recent, Marlene Puffer, departed in September. Article content Article content Aimco, which manages about $180 billion of pension capital and other money for the Canadian province, wants to increase its staff in Calgary to boost the city's financial sector. Newly appointed Chief Legal Officer John Walsh works out of the Calgary office, which has about 70 of Aimco's 680 employees. Article content 'The size of the team in Calgary has grown and we're looking for space to accommodate them,' Aimco spokesperson Carolyn Quick said. The firm is also changing its remote-work policy, requiring employees to work from the office three times a week starting in January, the people said. Article content Aimco's restructuring was set in motion on Nov. 7, when Alberta's finance minister sacked the board, Chief Executive Officer Evan Siddall and three other executives, saying they had allowed expenses to soar to unacceptable levels. Ray Gilmour was named interim CEO and Stephen Harper, the former Canadian prime minister, was installed as chair. Article content Article content Since then, the money manager's global expansion, championed by Siddall, has reversed. It shuttered its offices in New York and Singapore and parted ways with David Scudellari, its global head of private assets, and Kevin Bong, the executive who ran the Singapore office. Article content Last month, Aimco laid off around a dozen employees and decided to freeze around 25 vacant roles, according to one of the people. Earlier this year, Aimco eliminated 19 jobs, including the role responsible for the diversity, equity and inclusion program. Article content Aimco produced a 12.6% return last year in its balanced fund, missing its benchmark of 13.4%. Its total fund return was 12.3%. But the fund's results exceeded those of some peers in the so-called Maple Eight, such as Ontario Municipal Employees Retirement System and Ontario Teachers' Pension Plan, which last year earned 8.3% and 9.4%, respectively.
